Bajaj HealthCare Limited (BAJAJHCARE.BO)
INR 593.0
(6.08%)
INR 593.0
(6.08%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 4.73 Billion | 6.73 Billion | 6.79 Billion | 6.55 Billion | 4.07 Billion | 3.23 Billion |
| Cost of Revenue | 3.26 Billion | 4.9 Billion | 4.96 Billion | 4.62 Billion | 3.12 Billion | 2.41 Billion |
| Gross Profit | 1.47 Billion | 1.82 Billion | 1.83 Billion | 1.92 Billion | 948.25 Million | 821.42 Million |
| Operating Expenses | 985.34 Million | 1.03 Billion | 829.72 Million | 716.42 Million | 481.63 Million | 477.12 Million |
| Selling, General and Administrative Expenses | 985.34 Million | 227.39 Million | 70.51 Million | 61.37 Million | 31.93 Million | 33.51 Million |
| Research and Development Expenses | - | 38 Million | 26.14 Million | 45.32 Million | 22.29 Million | - |
| Other Expenses | - | 15.97 Million | 14.44 Million | 13.76 Million | 2.19 Million | 1.53 Million |
| Cost and Expenses | 4.24 Billion | 5.93 Billion | 5.79 Billion | 5.34 Billion | 3.61 Billion | 2.88 Billion |
| Operating Income | - | 836.37 Million | 1.05 Billion | 1.24 Billion | 439.45 Million | 363.24 Million |
| Interest Expense | 296.79 Million | 228.72 Million | 126.23 Million | 83.37 Million | 66.3 Million | 71.1 Million |
| Income Tax Expense | -23.48 Million | 151.91 Million | 182.98 Million | 357.1 Million | 108.23 Million | 78.59 Million |
| Earnings before Tax | -166.75 Million | 582.16 Million | 896.84 Million | 1.18 Billion | 360.6 Million | 241.69 Million |
| Net Income | -837.93 Million | 430.24 Million | 713.85 Million | 831.08 Million | 252.36 Million | 163.1 Million |
| Earnings Per Share Basic | -30.36 | 15.59 | 25.87 | 30.11 | 9.14 | 5.91 |
| Earnings Per Share Diluted | -30.36 | 15.59 | 25.87 | 30.11 | 9.14 | 5.91 |
| Weighted Average Shares Outstanding | 27.59 Million | 27.59 Million | 27.59 Million | 27.59 Million | 27.59 Million | 27.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.59 Million | 27.59 Million | 27.59 Million | 27.59 Million | 27.59 Million | 27.59 Million |
| Gross Margin | 0.31 | 0.27 | 0.27 | 0.29 | 0.23 | 0.25 |
| EBIT Margin | 0.09 | 0.16 | 0.18 | 0.22 | 0.14 | 0.13 |
| Profit Margin | -0.18 | 0.06 | 0.10 | 0.13 | 0.06 | 0.05 |
| EBITDA | 444.51 Million | 1.12 Billion | 1.19 Billion | 1.43 Billion | 546.32 Million | 435.97 Million |
| Earnings Before Tax Margin | - | 0.12 | 0.16 | 0.19 | 0.11 | 0.11 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.32 Billion | 1.33 Billion | 4.73 Billion | 1.08 Billion | 1.01 Billion | 1.29 Billion |
| Cost of Revenue | 850.18 Million | 1.01 Billion | 3.26 Billion | 512.9 Million | 448.53 Million | 749.29 Million |
| Gross Profit | 472.28 Million | 322.85 Million | 1.47 Billion | 572.81 Million | 563.56 Million | 548.07 Million |
| Operating Expenses | 294.53 Million | 235.49 Million | 985.34 Million | 450.99 Million | 440.66 Million | 393.69 Million |
| Selling, General and Administrative Expenses | 294.53 Million | 235.49 Million | - | 260.96 Million | 262.9 Million | 225.97 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 8.54 Million | 64.53 Million | 86.86 Million | 7.97 Million | 12.17 Million | 2.18 Million |
| Cost and Expenses | 1.14 Billion | 1.25 Billion | 4.24 Billion | 963.9 Million | 889.19 Million | 1.14 Billion |
| Operating Income | 177.74 Million | 87.36 Million | 486.46 Million | 121.82 Million | 122.9 Million | 154.37 Million |
| Interest Expense | 84.44 Million | 60.1 Million | 296.79 Million | 66.54 Million | 82.63 Million | 87.5 Million |
| Income Tax Expense | 21.57 Million | -31.48 Million | -23.48 Million | 8.01 Million | 1.2 Million | -1.21 Million |
| Earnings before Tax | 101.84 Million | -351.49 Million | -166.75 Million | 63.25 Million | 52.43 Million | 69.04 Million |
| Net Income | 71.31 Million | -299.24 Million | -837.93 Million | -21.96 Million | -34.6 Million | -482.11 Million |
| Earnings Per Share Basic | 2.58 | -10.84 | - | -0.80 | -1.25 | -17.47 |
| Earnings Per Share Diluted | 2.58 | -10.84 | - | -0.80 | -1.25 | -17.47 |
| Weighted Average Shares Outstanding | 27.59 Million | 27.59 Million | 27.59 Million | 27.59 Million | 27.59 Million | 27.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.59 Million | 27.59 Million | 27.59 Million | 27.59 Million | 27.59 Million | 27.59 Million |
| Gross Margin | 0.36 | 0.24 | 0.31 | 0.53 | 0.56 | 0.42 |
| EBIT Margin | 0.19 | 0.12 | - | 0.19 | 0.20 | 0.17 |
| Profit Margin | 0.05 | -0.22 | -0.18 | -0.02 | -0.03 | -0.37 |
| EBITDA | 245.04 Million | 160.34 Million | - | 203.34 Million | 201.67 Million | 219.62 Million |
| Earnings Before Tax Margin | 0.13 | 0.07 | 0.10 | 0.11 | 0.12 | 0.12 |
POLYMED
IFSUF
CSPI
3417
0295
FISB